Profile picture

Doctor Lourdes Vicent Alaminos

12th of October University Hospital, Madrid (Spain)
Follow
Logo ESC

Contributor content

Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction
Presentation
Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction
Seasonality in mortality in a cardiology department: a five-year analysis
Presentation
Seasonality in mortality in a cardiology department: a five-year analysis
Clinical profile of a cohort of patients presenting sustained ventricular arrhythmias shortly after sacubitril/valsartan initiation.
Presentation
Clinical profile of a cohort of patients presenting sustained ventricular arrhythmias shortly after sacubitril/valsartan initiation.
Statin use in octogenarians after a non-ST segment elevation acute coronary syndrome.
Presentation
Statin use in octogenarians after a non-ST segment elevation acute coronary syndrome.
An overview of end-of-life issues in a cardiology department. Is the mode of death worse in the cardiac intensive care unit?
Presentation
An overview of end-of-life issues in a cardiology department. Is the mode of death worse in the cardiac intensive care unit?
Elderly females with acute coronary syndrome present frailty and readmissions more frequently than males
Presentation
Elderly females with acute coronary syndrome present frailty and readmissions more frequently than males
Sacubitril/valsartan improves functional class and objective parameters in heart failure patients with reduced ejection fraction and its discontinuation is associated with a poor prognosis.
Presentation
Sacubitril/valsartan improves functional class and objective parameters in heart failure patients with reduced ejection fraction and its discontinuation is associated with a poor prognosis.
The clinical profile of a non-selected population treated with sacubitril/valsartan is different from PARADIGM-HF trial
Presentation
The clinical profile of a non-selected population treated with sacubitril/valsartan is different from PARADIGM-HF trial
Sailing in troubled waters: the key role of ECMO circulatory support in arrhythmic storm
Presentation
Sailing in troubled waters: the key role of ECMO circulatory support in arrhythmic storm
Arrhythmic storm after initiating sacubitril/valsartan
Presentation
Arrhythmic storm after initiating sacubitril/valsartan

ESC 365 is supported by